NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 22 May · 16:34 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet on May 28, 2026

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹16681.00
prior close
₹16785.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+1.1+0.6+0.5+2.7+0.4+2.5+3.1+1.3+1.3+0.2+7.7+13.9
Up moveDown movePending
AI summary

Neuland Laboratories has disclosed that its management will participate in a group analyst/institutional investor meeting on May 28, 2026, at the 360 ONE Capital (B&K) 16th Annual Investor Conference called Trinity India 2026 in Mumbai. The meeting will be conducted as both a group meet and one-on-one format. This disclosure is made under SEBI's Regulation 30 (LODR Regulations, 2015) which mandates listed companies to inform exchanges about scheduled investor meetings. The company noted that the schedule may change due to exigencies.

Likely market impact

This is a routine regulatory disclosure with no material information. The meeting indicates ongoing engagement between Neuland's management and institutional investors but does not convey any new business developments, financial guidance, or investment recommendations.